EUVIMEDEUVIMED entdecken
Crossref

Survival outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab: a comparison between ECOG performance status 0–1 and 2

Tanju Kapagan, Beyza Canan Ozkan Kardes, Cagla Ecem Kılıc, Ece Yontan, Mehmet Turkmencalikoglu, Zozan Ozcalimli, Beyza Arslansoy, Nilufer Bulut, Gokmen Umut Erdem

Oncology in Clinical Practice · 15.01.2026 · 22

DOI: 10.5603/ocp.111890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Tanju Kapagan und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kapagan, T., Kardes, B. C. O., Kılıc, C. E., Yontan, E., Turkmencalikoglu, M., Ozcalimli, Z., Arslansoy, B., Bulut, N., & Erdem, G. U. (2026). Survival outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab: a comparison between ECOG performance status 0–1 and 2. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.111890

Vancouver

Kapagan T, Kardes BCO, Kılıc CE, Yontan E, Turkmencalikoglu M, Ozcalimli Z, et al. Survival outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab: a comparison between ECOG performance status 0–1 and 2. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.111890

BibTeX
@article{Kapagan2026,
  author = {Kapagan, Tanju and Kardes, Beyza Canan Ozkan and Kılıc, Cagla Ecem and Yontan, Ece and Turkmencalikoglu, Mehmet and Ozcalimli, Zozan and Arslansoy, Beyza and Bulut, Nilufer and Erdem, Gokmen Umut},
  title = {Survival outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab: a comparison between ECOG performance status 0–1 and 2},
  journal = {Oncology in Clinical Practice},
  year = {2026},
  volume = {22},
  number = {0},
  doi = {10.5603/ocp.111890}
}
Kostenlos starten →